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Intrapartum electronic fetal monitoring (EFM) using cardiotocography (CTG) is the 
recommended method for monitoring the fetal heart rate during labour for high-risk births in 
England.1 An abnormal CTG indicates the need for further review and management including 
potential urgent intervention (e.g. expediting birth) to minimise risk of serious long-term harm 
to the baby or stillbirth. In the UK, as other European countries, sub-optimal intrapartum EFM 
management is implicated in a large share of cerebral palsy, birth asphyxia, peripartum 
hypoxic brain injuries and obstetric malpractice claims.2-5  In addition to the psychosocial and 
social impact of stillbirth or life-long disability on parents and babies, obstetric brain injury is 
costly, 6 potentially resulting in settlements for millions of pounds to support families over a 
lifetime of care. Every baby born in the NHS in England now incurs indemnity costs of £1,100. 
Of the total Clinical Negligence Scheme for Trusts provision of £78bn, 70% relates to 
maternity. 7 Though maternity claims made up just 10% of the number of clinical negligence 
claims received by NHS Resolution in 2018-19, they accounted for 50% of the total value of 
claims. 7  The need for action to improve safety of intrapartum EFM is now urgent, but 
questions remain about how it can best be achieved. 
We propose that reducing avoidable harm linked to intrapartum EFM requires sound 
understanding of the influences on sub-optimal practice. However, current approaches to 
improvement have tended to focus overwhelmingly on one element of the system – 
interpretation of CTG traces – and have also tended to focus on one type of solution – 
specifically training.  There can be no doubt of the relevance of CTG interpretation to quality of 
care. High rates of inter- and intra-observer variability in interpretation of CTG traces are often 
reported. 8 9 However, the evidence that CTG interpretation training on its own is effective is 
weak. As early as 2007, 98% of UK maternity units declared that they complied with the 
requirement that six-monthly training sessions on high-risk labour and CTGs be attended by all 
clinicians.10 But reports continue to attribute cases of cerebral palsy and stillbirths to poor CTG 
interpretation and failure to act on abnormal CTGs,2 6  suggesting that just training staff in CTG 
interpretation alone is not enough to improve quality of care in relation to intrapartum EFM. 
In addition, technology does not appear to be the answer to the interpretation challenge, at 
least at present:  a recent (2017) large randomised controlled trial of a computerised decision 
support system for electronic fetal monitoring did not indicate any benefit to clinical 
outcomes.11 One explanation is that responses for abnormal intrapartum CTG traces were 
variable, indicating a potential systems issue going beyond the specifics of interpretation.12   
In recent years, efforts have been made to acknowledge the wider context of EFM beyond 
interpretation. The 2015 RCOG report recommended that EFM training should promote team-
working and include non-clinical skills such as situational awareness.13 The 2019 NHS Saving 
Babies’ Lives Care Bundle 2 specifies that EFM training must include situational awareness 
and human factors, 14 although there is currently no standardised curriculum which outlines the 
nature of such training, and local training approaches are variable.  
   
 4
  
A perhaps more fruitful approach than one that focuses solely on CTG interpretation, more 
technology and/or solely on training, is to look more broadly at influences on safety. 15 Such an 
approach would be consistent with the literature in patient safety that has advocated a 
systems approach to understanding and addressing the effects and interactions of real-world 
contexts such as teamwork, tasks, equipment, workspace, culture and organisation on clinical 
performance. 16 17 It is also consistent with a well-established definition of safety as an attribute 
of health systems: 
Patient safety is a discipline in the health care sector that applies safety science 
methods toward the goal of achieving a trustworthy system of health care delivery. 
Patient safety is also an attribute of health care systems; it minimizes the incidence 
and impact of, and maximizes recovery from, adverse events. 18 
Many relevant influences on patient safety have been summarised in the Yorkshire 
Contributory Factors framework (the Framework) (Figure 1), an evidence-based conceptual 
framework of 20 domains (and a definition for each) that may contribute to patient safety 
incidents in hospitals. 15  It is based on a synthesis of 95 reports of 83 studies conducted in 
multiple healthcare settings, including general hospital (30), intensive care (17), surgery (16), 
and anaesthesia (7). The 20 domains generated from the studies reviewed by the authors 
range from the situational (e.g. individual or team factors) to the external, such as national 
policies. 
A particularly welcome feature of the Framework is that it seeks to avoid excessive focus on 
proximal causes of incidents (active failures) and instead broadens to a more systems-based 
approach that considers how working conditions and latent factors may be highly 
consequential.  Across the study settings reviewed by the authors of the Framework, the five 
contributory factors identified most frequently in the 95 studies reviewed by the authors were 
active failures (slips, lapses, mistakes, deviations from policy) (18.2%), individual factors 
(11%), communication (7.9%), equipment and supplies (6.6%) and management of staff and 
staffing levels (5.8%). Active failures and individual factors were the most frequently identified 
contributory factors, but team factors (8.5%) were reported among the top five contributory 
factors for surgery and for no other setting, while in anaesthesia, equipment and supplies was 
the second most cited contributory factor, accounting for 15.2%. Physical environment was 
also among the top five factors. For the general hospital setting, patient factors (7.4%) were 
among the highest ranked contributory factors but equipment and supplies were not. 
An approach that draws on this kind of framework is likely to be of considerable value in 
characterising the influences on intrapartum EFM safety in maternity units, where issues such 
as work organisation, availability of senior support, and professional boundaries are known to 
play a role. 6 19-21 However, the evidence about what is known regarding the specific influences 
on EFM and labour management has not been systematically collated nor organised into this 
kind of explanatory framework. This absence limits the development of a fully characterised 
systems approach to the area and inhibits recognition of which issues have received most and 
least attention in building the evidence base.  Addressing this void is the goal of our proposed 
review, with the aim of identifying new areas for intervention and determining what kinds of 
training, interventions and service delivery and organisation are required to improve maternal 
and fetal outcomes. 
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Figure 1: The Yorkshire Contributory Factors framework 
 
(reproduced from Lawton et al, 2012 15) 
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2 Review question and objectives 
We will conduct a scoping review of the literature to answer the following question:  
 What are the influences on patient safety of intrapartum electronic fetal monitoring 
(EFM) with cardiotocography (CTG) in hospital-based maternity care settings?  
Our primary objective is to provide an overview of the available evidence that can help in 
identifying and characterising the range of influences on safety of EFM, using an end-to-end 
systems approach, including but not limited to interpretation, response, and management of 
CTG traces.  A secondary objective is to identify which influences feature most strongly in the 
literature so that that an assessment can be made of which topics have thus far received most 
research attention, and which might benefit from further study. 
The review does not aim to examine the effectiveness of CTG training, which is the subject of 
a separate systematic review (Health professional training for cardiotocography interpretation 
and management; PROSPERO reference CRD42018082567).  
3 Methods and analysis 
We will use a scoping review approach, because of the particular value of this method when 
there is a need to explore concepts, map the nature and type of available evidence for a 
question, or conduct a first comprehensive review of a body of literature. 22 23 Scoping reviews 
‘follow a systematic approach to map evidence on a topic and identify main concepts, theories, 
sources, and knowledge gaps’, 22  and can be contrasted with systematic reviews, which seek 
to address a clearly defined question. Scoping reviews do not aim to examine the 
effectiveness of interventions. 
Our review will combine scoping methodology with a best-fit framework synthesis approach, 24 
25 using the domains of the Framework to organise the initial analysis.  
3.1 Conduct and reporting 
Methods for the conduct and reporting of the systematic scoping review will follow the 
guidelines of the PRISMA-ScR statement. 22 There is currently no specific guidance for 
reporting a protocol for a systematic scoping review, so this protocol has been developed 
based on key elements of the PRISMA-P guidance, 26 earlier scoping review frameworks 23 27  
and the PRISMA-ScR statement. 22  
 
PROSPERO 28 does not currently accept registrations for scoping reviews so this protocol is 
being made publicly available on the THIS Institute website 
(https://www.thisinstitute.cam.ac.uk/) and institutional repositories.  
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3.2 Eligibility criteria 
Given the wide scope of the review and the literature, the inclusion/exclusion criteria and 
search strategies have been developed through initial exploratory searches, piloting of title 
and abstract screening and an iterative learning process and discussion about areas of 
uncertainty in collaboration between THIS Institute and RAND Europe. 
3.2.1 Types of studies 
We will include empirical studies (primary empirical research or secondary data analysis of 
primary empirical data) that report data concerning influences on the clinical practice of 
intrapartum electronic fetal heart rate monitoring with cardiotocography in hospital-based 
maternity care settings.  
Study designs will not be restricted: we will include interventional and observational 
quantitative designs (i.e. randomised controlled trials, controlled trials, before-and-after 
intervention study designs, cohort studies, cross-sectional studies), qualitative studies, case 
reports and case studies. We will include research articles from peer-reviewed journals and 
conference proceedings and relevant grey literature reports, published in English  
Editorial material, letters and literature reviews (literature reviews, systematic reviews, meta 
analyses) will be excluded. Reference lists of any relevant reviews identified will be hand-
searched. We note that some relevant journals, such as ANZJOG, do not have a traditional 
abstract written by the authors, but instead provide an editorial comment: despite this, these 
studies are regular peer-reviewed articles, and they will not be excluded at initial screening 
unless they clearly meet exclusion criteria.  
Studies from lower or middle income (LMIC) countries (as defined by the World Bank 29) will 
be excluded as LMIC countries may be less likely to use EFM or have less capacity to take 
action if abnormalities are identified). 
3.2.2 Date of publication 
Studies published from 2001 onwards will be included. UK and US national guidelines on EFM 
were introduced after this date; findings from before 2001 are less likely to be relevant to 
current practice. 
3.2.3 Population 
We will include studies relevant to intrapartum EFM and CTG interpretation in hospital-based 
maternity care including (but not limited to) the roles of obstetricians, midwives and other 
members of the maternity team, wider organisational and environmental influences and 
maternal and fetal experience. 
3.2.4 Focus of studies 
The primary focus for inclusion is studies that report influences on maternal and/or fetal safety 
in relation to EFM.  In keeping with the Framework and the systems approach to patient 
safety, we will not limit our analysis to proximal influences on safety.  For example, some 
studies have analysed the impact of architecture on coordination, communication and 
situational awareness in maternity units in general 30 which in turn may affect EFM. These 
studies will be included.  




3.2.5 Phenomena of interest 
Phenomena of interest are (i) findings relating to safety of EFM as described in the domains of 
the Framework (ii) any further relevant influences identified by our review that do not fit in 
these domains. 
3.2.6 Setting 
We will only include studies in hospital intrapartum maternity care settings (i.e. delivery 
suites/labour wards).  
3.2.7 Exclusion criteria 
 Studies that relate to EFM but do not report on patient safety. 
 Fetal heart rate monitoring using non-electronic methods (such as intermittent 
auscultation); studies reporting about the partogram unless EFM is also reported. 
 Studies focusing on: pre-birth (ante-natal) monitoring only; non-stress tests (NST), 
contraction stress tests (CST) and oxytocin challenge tests (OCT) as they are 
performed before labour, as part of antepartum surveillance.  
 Studies that focus on a link between a specific clinical intervention (e.g. caesarean 
section) and a clinical outcome (e.g. cerebral palsy), without a plausible link to factors 
related to EFM performance.  
 Studies that report the prediction/diagnostic relationship between CTG traces and fetal 
outcomes. 
 Studies that report patient safety incidents without an examination of the factors that 
contributed to incidents.  
 The review does not aim to consider the effectiveness of interventions targeted at staff 
training or education about CTG (as this is the subject of an ongoing systematic review 
as described previously). However, contextual issues around these topics such as lack 
of training influencing CTG interpretation and response, or factors that may affect 
uptake or participation in education or training will be included.  
 The review does not aim to consider the effectiveness of new or different technologies 
for EFM such as technical algorithms, waveform analyses, technical add-ons to CTG, 
computerised interpretation.  
 Studies not published in English. 
 Studies conducted in lower or middle income (LMIC) countries. 
 
3.3 Information sources and search strategy 
3.3.1 Databases 
A number of approaches will be taken to identify relevant literature. 
The following electronic sources will be searched for peer-reviewed studies and conference 
abstracts published in the English language: MEDLINE; EMBASE; CINAHL; Web of Science; 
Scopus, British Nursing Database (formerly British Nursing Index), Cochrane library. 
Combining MEDLINE and CINAHL is recommended when searching for qualitative research.31 
The Web of Science Core Collection and Scopus will be included because they cover a 
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broader disciplinary range, including social sciences, management, and engineering, which 
may include useful references.  
A draft database search strategy for MEDLINE is shown in Appendix 1. This search strategy 
was developed with the involvement of an experienced medical librarian and information 
specialist (IK), following initial exploratory searching and scoping and analysis of search hits. 
The categories of the Framework and advice on relevant search terms from an obstetrician 
(TD) and a midwife (CW) with professional experience of intrapartum EFM/CTG were also 
used to inform the searches. The search strategy will be translated as appropriate for the other 
electronic databases.  
The search strategy developed combines keywords and MeSH terms (1) related to safety 
concerns in medical and maternity care and to good and poor practice, maternal and fetal 
outcomes and other issues related to maternity care, and (2) related to the use of EFM/CTG in 
labour, e.g. fetal heart rate monitoring or cardiotocogram. 
Additional targeted searches, hand searching and forward and backward citation searching 
will also be conducted as appropriate using a flexible, iterative approach consistent with 
scoping review methodology to identify any further potentially relevant studies. 
3.3.2 Grey literature 
We will also conduct a targeted search of the grey literature. We will search websites of 
national professional bodies relating to obstetrics, midwifery and patient safety to identify key 
reports from public authorities and national professional bodies (e.g. NICE; Royal College of 
Obstetricians and Gynaecologists; Royal College of Midwives; NHS Resolution; FIGO), that 
specifically relate to EFM recommendations and practice. Further grey literature searches will 
be conducted in NICE Evidence, OpenGrey and OpenSIGLE. Additionally, we will conduct 
complementary searches of Google Scholar using the same search terms and concepts as the 
database searches.  
3.4 Selection of evidence 
Search hits will be downloaded and screened using reference management software and/or 
other screening software/interfaces. Title and abstract screening will be conducted 
independently by at least two reviewers. Disagreements between the two reviewers will be 
resolved by discussion and with the involvement of a third reviewer if necessary. Full texts of 
potentially relevant papers will be obtained and screened independently by two researchers. In 
case of disagreement a third reviewer will arbitrate the final decision. The same screening 
criteria will be applied at both the title and abstract and full text screening stages. A PRISMA 
flow chart 32 will be used to document the study selection process. 
3.5 Data extraction and data charting 
For each paper included in the review, data will be extracted relating to study characteristics 
and key demographics. A standard template will be developed and piloted by the team before 
use. Data will be presented in the form of summary tables and/or diagrams for: 
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(1) study characteristics (study reference, year, country of origin, study design and 
type of evidence in relation to the factors reported (e.g. quantitative, qualitative, 
experimental, observational, case studies)); 
(2) key demographics where relevant e.g. for patients/participants (such as age, 
gender, health status, socioeconomic status, ethnicity); 
(3) Any other contextual information of relevance; 
 
This data extraction will be conducted by an experienced reviewer and cross-referenced with a 
second reviewer, with disagreements resolved by discussion. A formal quality assessment will 
not be conducted as this is not usually included within a scoping review. 22 However, as 
described above, the data tabulation process will report the sources and type of evidence. 
Further data extraction, relating to key findings of included studies, will be undertaken 
alongside data synthesis, as is typical in a best-fit framework synthesis approach: details of 
this are given below.  
3.6 Synthesis of results 
The review will seek to map relevant findings from the included studies onto the Framework 15  
guided by a best-fit framework synthesis approach. 24 25 A coding framework will initially be 
created based on the 20 domains of the Framework. Relevant evidence to address the 
research question will be identified in the included studies and will be coded appropriately, 
facilitated by NVivo and/or Excel software. Some findings may fit into more than one domain, 
and multiple coding will be used as required. Where several papers report similar findings, 
these may be grouped together thematically where appropriate. “Memos” akin to those used in 
qualitative analysis will be used to capture coding decisions, facilitate analytic depth, and 
ensure sensitisation to emerging constructs.  
Where evidence does not satisfactorily fit the domains of the existing Framework, thematic 
analysis of relevant findings will be used to generate new domains to add to the coding 
framework. Such domains will be created in discussion with the review team, and the 
developing coding framework will be reviewed regularly to ensure continuing relevance to the 
research question concerning influences on safety of intrapartum electronic fetal monitoring 
(EFM) with cardiotocography (CTG). 
Initial coding and mapping will be conducted by an experienced reviewer and cross-referenced 
with a second reviewer. Disagreements between reviewers will be resolved by discussion or 
by arbitration with a third experienced reviewer. Regular project team meetings will facilitate 
close scrutiny of coding decisions and the emerging framework.  
The  Yorkshire Contributory Factors Framework is well-suited to the aims of this review: it was 
developed from identified patient safety incidents, it is relevant to studies in a hospital setting, 
and it provides categories/domains which are generic across a range of different types of 
treatment and care, including those relating to: failures in performance or behaviour; 
communication systems; design of equipment and supplies; external policy context; individual 
factors; lines of responsibility; management of staff and staffing levels; patient factors; physical 
environment; policy and procedures; safety culture; scheduling and bed management; staff 
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workload; supervision and leadership; support from central functions; task characteristics; 
team factors; training and education.  The mapping will, in keeping with the Framework, 
distinguish between active failures, situational factors, local working conditions, latent-
organisational factors, and latent external factors.   
Use of the Framework will help in systematically identifying and characterising a wide range of 
influences on safety related to intrapartum EFM and CTG as reported in the literature, and will 
also help to identify which influences have received most attention to date in the research 
literature.  
Note: additional members of the project team who may assist with selection of evidence, data 
extraction, data synthesis and charting are listed in Appendix 2. 
4 Involvement of healthcare 
professionals (knowledge users) 
This protocol has been developed with the involvement of experienced obstetricians and 
midwives with professional experience of using, and developing training for, intrapartum EFM 
and CTG interpretation (TD, CW). These professionals have advised on terms for the draft 
search strategy, and provided feedback on the protocol. They will also advise and feedback on 
the synthesis, discussion and conclusions of the full review.  
5 Other stakeholders 
RAND Europe as a partner of THIS Institute have been involved in development and piloting 
of the search strategy and inclusion/exclusion criteria for this protocol and will participate in the 
screening process.  
6 Ethical approval 
As this review will use published literature in the public domain, ethical approval is not needed. 
7 Dissemination 
A full report of the methods and results of the scoping review will be published as a paper in a 
high quality, peer-reviewed journal. Further dissemination will be conducted through social 
media, the website of THIS institute and the networks and contacts of THIS Institute. In 
addition, it is hoped that this report will help to inform future guidance and practice for clinical 
staff via their national professional bodies. 
 




This work is part of THIS Institute’s research programme and is funded by the Health 
Foundation’s grant for THIS Institute to the University of Cambridge. The Health Foundation is 
an independent charity committed to bringing about better health and health care for people in 
the UK. The Health Foundation have had no involvement in the development of this protocol. 
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Appendix 1: Draft search strategy (MEDLINE) 
Medline 
Database: Ovid MEDLINE(R) and Epub Ahead of Print, In-Process & Other Non-Indexed 
Citations, Daily and Versions(R) <1946 to October 22, 2018> 
Search Strategy: 
-------------------------------------------------------------------------------- 
1 exp malpractice/ or exp "Drug-Related Side Effects and Adverse Reactions"/ or exp 
jurisprudence/ or exp legal cases/ or exp medical error/ or exp diagnostic error/ or exp 
accidents/ or exp risk/ or exp protective factors/ or exp "Compensation and Redress"/ 
or exp "quality of health care"/ or exp maternal mortality/ or exp infant mortality/ or exp 
fetal death/ or exp hospital mortality/ or exp morality/ or exp perinatal mortality/ or 
(Adverse or negligen* or medicolegal or medico-legal* or legal or illegal* or liabil* or 
safe* or claim* or litigat* or malpractice or error* or risk* or prevent* or fail* or accident* 
or incident* or mistak* or compensat* or ((good or bad* or poor* or best) adj3 (practic* 
or perform*)) or interpret* or misinterpret* or substandard* or quality or standard* or 
mortality or death*).mp.  
2 (exp hypothermia, induced/ or ((induc* or therap*) adj3 (cool* or hypotherm*)).mp.) and 
(exp infant, newborn/ or (neonat* or infant* or newborn*).mp.) 
3 (exp stillbirth/ or (stillbirth* or stillborn or (still adj (born* or birth*))).mp.)  
4 (Exp infantile spasms/ or ((exp seizures/ or exp epilepsy/ or (seizure* or fit or fitting or 
fits or epilep*).mp.) and (exp infant, newborn/ or (neonat* or infant* or newborn*).mp.)) 
5 (exp brain diseases/ or (encephalo* or ((diseas* or disorder*) and (brain* or 
intracranial*)) ).mp.) and (exp infant, newborn/ or (neonat* or infant* or newborn*).mp.) 
6 (exp apgar score/ or apgar.mp.)  
7 (exp umbilical cord/ or (umbilical).mp.) and (exp delivery, obstetric/ or (intrapartum or 
birth* or delivery).mp.) and ( exp acidosis/ or (acidosis or acidity or ph).mp.) 
8 (((exp patient admission/ or exp patient transfer/) and (unexpect*).mp.) or (unexpect* 
adj3 (admission* or admit* or transfer*)).mp.) AND (exp intensive care, neonatal/ or 
exp intensive care units, neonatal/ or (nicu or (neonatal adj (critical or intensive) adj 
care)).mp.) 
9 exp Cerebral palsy/ or exp asphyxia neonatorum/ or exp hypoxia-ischemia, brain/ or 
exp fetal hypoxia/ or exp hypoxia-ischemia, brain/ or exp pregnancy outcome/ or exp 
obstetric labor complications/ or exp pregnancy complications/ or cerebral palsy.mp. or 
(asphyx* adj3 (neonat* or birth* or intrapartum* or f?etus*)).mp. or hypoxi*.mp. or 
(complicat* adj3 (pregnan* or labo?r* or birth* or deliver*)).mp.  
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10 exp ABRUPTIO PLACENTAE/ or exp uterine rupture/ or (Abruptio* or pr?evia).mp. or 
((ruptur* or tear* or separat* or torn* or solutio) adj3 (placent* or uteru* or 
uterine*)).mp.   
11 or/1-10 
12 exp Cardiotocography/ or exp fetal monitoring/ or ((f?etal or intrapartum*) adj2 
(monitor* or heartbeat* or (heart adj2 (beat* or rate)) or distress* or surveillanc* or 
status)).mp. or (ctg or cardiotoco*).mp. or ("continuous electronic monitoring" adj3 
(labo?r or delivery or intrapartum* or birth*)).mp. or ((f?etal or intrapartum) adj5 
(decelerat* or accelerat* or variab*)).mp. or ((late or early) adj3 decelerat*).mp. 

































Appendix 2: Additional team members 
 
Additional team members who may assist with review tasks such as selection of evidence, 
data extraction, data synthesis and charting: Xueying Nancy Zheng, Harry Kyriacou, Alice 
Egerton, Zi Qi Kok and Kathryn Jones. 
